Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model
Authors:
- 9 June 2015
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 52 (2) , 979-984
Abstract
Dodecafluoropentane emulsion (DDFPe) nanodroplets are exceptional oxygen transporters and can protect ischemic brain in stroke models 24 h without reperfusion. Current stroke therapy usually fails to reach patients because of delays following stroke onset. We tested using DDFPe to extend the time window for tissue plasminogen activator (tPA). Longer treatment windows will allow more patients more complete stroke recovery. We test DDFPe to safely extend the time window for tPA thrombolysis to 9 h after stroke. With IACUC approval, randomized New Zealand white rabbits (3.4–4.7 kg, n = 30) received angiography and 4-mm blood clot in the internal carotid artery for flow-directed middle cerebral artery occlusion. Seven failed and were discarded. Groups were IV tPA (n = 11), DDFPe + tPA (n = 7), and no therapy controls (n = 5). DDFPe (0.3 ml/kg, 2 % emulsion) IV dosing began at 1 h and continued at 90 min intervals for 6 doses in one test group; the other received saline injections. Both got standard IV tPA (0.9 mg/kg) therapy starting 9 h post stroke. At 24 h, neurological assessment scores (NAS, 0–18) were determined. Following brain removal percent stroke volume (%SV) was measured. Outcomes were compared with Kruskal-Wallis analysis. For NAS, DDFPe + tPA was improved overall, p = 0.0015, and vs. tPA alone, p = 0.0052. For %SV, DDFPe + tPA was improved overall, p = 0.0003 and vs. tPA alone, p = 0.0018. NAS controls and tPA alone were not different but %SV was, p = 0.0078. With delayed reperfusion, DDFPe + tPA was more effective than tPA alone in preserving functioning brain after stroke. DDFPe significantly extends the time window for tPA therapy.Keywords
This publication has 13 references indexed in Scilit:
- Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary reportMagnetic Resonance Imaging, 2015
- Heart Disease and Stroke Statistics—2014 UpdateCirculation, 2014
- Progress in Dodecafluoropentane Emulsion as a Neuroprotective Agent in a Rabbit Stroke ModelMolecular Neurobiology, 2013
- Dodecafluoropentane Emulsion Decreases Infarct Volume in a Rabbit Ischemic Stroke ModelJournal of Vascular and Interventional Radiology, 2012
- Successful Microbubble Sonothrombolysis Without Tissue-Type Plasminogen Activator in a Rabbit Model of Acute Ischemic StrokeStroke, 2011
- Microbubbles Improve Sonothrombolysis In Vitro and Decrease Hemorrhage In Vivo in a Rabbit Stroke ModelInvestigative Radiology, 2011
- Stroke Location and Brain Function in an Embolic Rabbit Stroke ModelJournal of Vascular and Interventional Radiology, 2010
- In VitroComparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen ExchangeArtificial Cells, Blood Substitutes, and Biotechnology, 2009
- EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids.1996
- Tissue Plasminogen Activator Reduces Neurological Damage After Cerebral EmbolismScience, 1985